|
1
|
Identification of common variants associated with human hippocampal and intracranial volumes.
|
Nat Genet
|
2012
|
3.73
|
|
2
|
Attention network hypoconnectivity with default and affective network hyperconnectivity in adults diagnosed with attention-deficit/hyperactivity disorder in childhood.
|
JAMA Psychiatry
|
2013
|
2.11
|
|
3
|
Effects of a novel schizophrenia risk variant rs7914558 at CNNM2 on brain structure and attributional style.
|
Br J Psychiatry
|
2013
|
2.06
|
|
4
|
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.
|
Brain Imaging Behav
|
2014
|
1.90
|
|
5
|
Compliance therapy: a randomised controlled trial in schizophrenia.
|
BMJ
|
2003
|
1.50
|
|
6
|
The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up.
|
Am J Psychiatry
|
2013
|
1.48
|
|
7
|
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia.
|
Arch Gen Psychiatry
|
2010
|
1.46
|
|
8
|
Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility.
|
Biol Psychiatry
|
2007
|
1.23
|
|
9
|
Childhood stress, serotonin transporter gene and brain structures in major depression.
|
Neuropsychopharmacology
|
2010
|
1.12
|
|
10
|
Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia.
|
Schizophr Bull
|
2012
|
1.06
|
|
11
|
A neuropsychological investigation of the genome wide associated schizophrenia risk variant NRGN rs12807809.
|
Schizophr Res
|
2010
|
0.96
|
|
12
|
Insulin-like growth factor 1 (IGF1) and its active peptide (1-3)IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms.
|
Neurosci Lett
|
2012
|
0.95
|
|
13
|
Neurocognition and suicidal behaviour in an Irish population with major psychotic disorders.
|
Schizophr Res
|
2006
|
0.90
|
|
14
|
Mental state decoding v. mental state reasoning as a mediator between cognitive and social function in psychosis.
|
Br J Psychiatry
|
2008
|
0.86
|
|
15
|
Chitinase-3-like 1 (CHI3L1) gene and schizophrenia: genetic association and a potential functional mechanism.
|
Biol Psychiatry
|
2008
|
0.86
|
|
16
|
Investigation of the apolipoprotein-L (APOL) gene family and schizophrenia using a novel DNA pooling strategy for public database SNPs.
|
Schizophr Res
|
2005
|
0.84
|
|
17
|
A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis.
|
Neurosci Lett
|
2007
|
0.84
|
|
18
|
Does the ability to sustain attention underlie symptom severity in schizophrenia?
|
Schizophr Res
|
2008
|
0.84
|
|
19
|
The effects of psychosis risk variants on brain connectivity: a review.
|
Front Psychiatry
|
2012
|
0.83
|
|
20
|
The miR-137 schizophrenia susceptibility variant rs1625579 does not predict variability in brain volume in a sample of schizophrenic patients and healthy individuals.
|
Am J Med Genet B Neuropsychiatr Genet
|
2014
|
0.82
|
|
21
|
The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals.
|
Neuroimage
|
2011
|
0.82
|
|
22
|
Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253.
|
Am J Med Genet B Neuropsychiatr Genet
|
2013
|
0.82
|
|
23
|
A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception.
|
Hum Brain Mapp
|
2011
|
0.81
|
|
24
|
Effect of genetic variant in BICC1 on functional and structural brain changes in depression.
|
Neuropsychopharmacology
|
2012
|
0.81
|
|
25
|
The effect of the neurogranin schizophrenia risk variant rs12807809 on brain structure and function.
|
Twin Res Hum Genet
|
2012
|
0.81
|
|
26
|
Social dysfunction in schizophrenia: an investigation of the GAF scale's sensitivity to deficits in social cognition.
|
Schizophr Res
|
2013
|
0.81
|
|
27
|
Functional genomics and schizophrenia: endophenotypes and mutant models.
|
Psychiatr Clin North Am
|
2007
|
0.80
|
|
28
|
Assessing patients' beliefs about their cancer-related fatigue: validation of an adapted version of the Illness Perception Questionnaire.
|
J Clin Psychol Med Settings
|
2012
|
0.80
|
|
29
|
Functional investigation of a schizophrenia GWAS signal at the CDC42 gene.
|
World J Biol Psychiatry
|
2012
|
0.79
|
|
30
|
Replicated genetic evidence supports a role for HOMER2 in schizophrenia.
|
Neurosci Lett
|
2009
|
0.79
|
|
31
|
D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.
|
Neurosci Lett
|
2007
|
0.79
|
|
32
|
Variance in facial recognition performance associated with BDNF in schizophrenia.
|
Am J Med Genet B Neuropsychiatr Genet
|
2007
|
0.77
|
|
33
|
Pro forma: impact on communication skills?
|
Clin Teach
|
2013
|
0.75
|
|
34
|
Adherence to a Low-Support Cognitive Remediation Training Program for Psychosis.
|
J Nerv Ment Dis
|
2016
|
0.75
|
|
35
|
Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.
|
Nat Commun
|
2015
|
0.75
|